Sign in

You're signed outSign in or to get full access.

Peter Bynoe

Director at Ardent Health
Board

About Peter Bynoe

Independent director of Ardent Health Partners since August 2015; age 74. Harvard College (BA, cum laude), Harvard Law School (JD), and Harvard Business School (MBA). Senior Advisor at DLA Piper; prior roles include Managing Director at Equity Group Investments (2014–2019), CEO of Rewards Network (2013–2014), and COO of Loop Capital Markets (2008–2013). The Board cites his strong legal and leadership experience across industries as core credentials .

Past Roles

OrganizationRoleTenureCommittees/Impact
DLA Piper LLP (US)Senior Advisor; previously Partner, Exec. Committee member, practice group leaderSince 1995Major infrastructure, corporate transactions
Equity Group Investments (EGI)Managing DirectorSep 2014–Dec 2019Led strategic diversification into healthcare; oversaw portfolio cos.
Rewards Network (EGI portfolio)Chief Executive OfficerSep 2013–Aug 2014Financing/marketing services for U.S. restaurants
Loop Capital MarketsChief Operating OfficerJan 2008–Aug 2013Full-service investment bank/broker dealer operations
Denver Nuggets (NBA)Owner & Managing General Partner1989–1992Team leadership and reorganization
Illinois Sports Facility AuthorityChairJan–Dec 2005Public infrastructure oversight
Chicago Commission on LandmarksChairFeb 1984–Sep 1997Urban governance
Chicago Plan CommissionChairOct 1997–Dec 2004Urban development planning

External Roles

OrganizationRoleTenureCommittees/Details
TKO Group Holdings (NYSE: TKO)DirectorSince Sep 12, 2023Compensation Committee member
Flagship Communities REIT (TSX: MHC.U)Chair of the Board; Independent TrusteeSince 2020Board leadership
RUSH University System for HealthTrusteeSince Jan 1994Healthcare governance
Goodman TheatreLife TrusteeSince Jan 1984Non-profit governance
Prior public boardsDirector (Covanta, Frontier, Real Industry, JACOR, Uniroyal, River Valley Savings Bank)Various 1991–2021Multiple sectors

Board Governance

  • Independence: Ardent is a “controlled company” (EGI-AM >50% voting power), but the Board determined eight independent directors in 2024; all except Bonick and Bulgarelli are independent, indicating Bynoe is independent under NYSE rules .
  • Committees (2024):
    • Nominating & Corporate Governance: Chair—Peter Bynoe; members Campion, Goodyear; Bulgarelli stepped down post-IPO; DeMichiei added Apr 2, 2025. Five meetings in 2024; charter available online .
    • Compensation: Members Bynoe, Bulgarelli, Sen, Campion, Havdala (Chair); nine meetings; as a controlled company, not required to be solely independent; EGI-AM designees can comprise a majority per Nomination Agreement .
    • Audit & Compliance: Chair—Goodyear; members Robinson, Sen, Webb; Bulgarelli stepped down post-IPO; DeMichiei added Apr 2, 2025; seven meetings; Audit Committee financial experts: Goodyear and DeMichiei .
  • Board activity: Six Board meetings in 2024; each director attended 75%+ of Board/committee meetings served .
  • Leadership: Chair—Mark Sotir; CEO—Marty Bonick; executive sessions at each regular meeting .

Fixed Compensation

YearCash Fees (Board + Committees)Equity Awards (Grant-Date Fair Value)Total
2024$105,000 $365,235 (Annual RSUs + Special Director RSUs) $470,235
  • Director program (post-IPO 2024 Program): Annual cash retainer $100,000; Annual Director RSUs grant-date value $185,000; additional annual cash retainers: Nominating Chair $15,000; Nominating member $7,500; Compensation Chair $20,000; Compensation member $10,000; Audit Chair $30,000; Audit member $15,000; Quality Chair $20,000; Quality member $10,000 .

Performance Compensation

Equity ComponentGrant/StatusVesting ScheduleNotes
Annual Director RSUs2024 grants under 2024 ProgramVest Mar 31, 2025 (one-year vest for 2024 cycle to align with historical timing); generally 12-month vest thereafter; accelerates on Change in Control under 2024 Plan
Special Director RSUsAdditional RSUs granted Dec 2024Vest in three equal tranches on Dec 12, 2025, Dec 12, 2026, Dec 12, 2027; similar acceleration/forfeiture terms as Annual RSUs
RSUs outstanding (as of Dec 31, 2024)22,355 RSUsN/AAggregate outstanding for Bynoe

No director stock options or PSUs disclosed; director equity is time-based RSUs under the 2024 Program .

Other Directorships & Interlocks

CompanyRolePotential Interlock/Exposure
Ardent Health Partners (NYSE: ARDT)Director; Nominating Chair; Compensation Committee memberControlled company; EGI-AM nomination rights; EGI-AM designees can comprise a majority of Nominating/Compensation Committees
TKO Group Holdings (NYSE: TKO)Director; Compensation Committee memberExternal comp oversight; no disclosed related-party links to ARDT
Flagship Communities REIT (TSX: MHC.U)Chair of the BoardIndependent trustee; no ARDT transactional ties disclosed

Expertise & Qualifications

  • Legal, finance, and operating leadership across law, private equity, investment banking; NBA franchise leadership; extensive public and non-profit board service .
  • Education: Harvard College (BA, cum laude), Harvard Law School (JD), Harvard Business School (MBA); Illinois Bar; registered real estate broker .

Equity Ownership

HolderShares Beneficially Owned% of ClassRSUs Included (vesting within 60 days)RSUs Outstanding (Dec 31, 2024)Ownership Guideline Compliance
Peter Bynoe77,427 <1% Includes RSUs vesting within 60 days of Mar 28, 2025 22,355 RSUs Non-employee directors must hold 5x annual cash retainer; as of Dec 31, 2024, all non-employee directors except Sotir and Sen exceeded the guideline (Bynoe in compliance)

Governance Assessment

  • Strengths: Independent status; chairs Nominating Committee; strong attendance (≥75%); meaningful equity holdings exceeding ownership guidelines; director equity with clear vesting schedules improves alignment .
  • Controlled company dynamics: EGI-AM’s Nomination Agreement allows EGI designees to comprise a majority of the Nominating and Compensation Committees while EGI-AM owns >50% voting power; this can reduce perceived independence of committee oversight despite formal independence determinations .
  • Compensation signals: Introduction of Special Director RSUs in Dec 2024 for retention following IPO; watch for ongoing use of retention equity that could reduce at-risk alignment if not tied to performance .
  • Related-party/transactions: No specific related-party transactions disclosed for Bynoe (e.g., law firm engagements) in the proxy; Audit & Compliance Committee oversees related-party reviews .
  • Board structure: Chair and CEO roles separated; executive sessions held at each regular meeting; this supports independent oversight .

Notes on Data Coverage

  • Director compensation, ownership, committee roles, independence, and attendance sourced from Ardent’s 2025 definitive proxy statement (DEF 14A) filed April 8, 2025 .
  • External directorships and TKO committee assignments verified via company investor relations sites and Flagship Communities REIT .
  • No Form 4 insider trade table is included; proxy provides beneficial ownership and RSUs outstanding as of March 28, 2025 and December 31, 2024, respectively .